Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today presented positive results from two clinical trials testing its lead anti-acne candidate, VB-1953, at the...
The number of clinical trials involving medicines and medical devices is on the increase in Ireland, a national seminar has been told. Currently in Ireland, there are 423 clinical trials offering patient access to innovative therapies, excluding cancer trials...
CytoDyn Inc. a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announces an agreement with The Cleveland Clinic’s Dr. Daniel Lindner, M.D., Ph.D. to test leronlimab’s ability...
BioCryst Pharmaceuticals, Inc. (BCRX) today announced the completion of a randomized, placebo-controlled Phase 1 clinical trial to evaluate intravenous (IV) galidesivir in healthy volunteers. In the trial, galidesivir was generally safe and well tolerated. This...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) informed today that the Alzheimer’s Clinical Trials Consortium (ACTC) and BioArctic’s partner Eisai have announced the selection of BAN2401 to be evaluated in an upcoming clinical study targeting secondary...
Merus N.V. (Nasdaq: MRUS), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today announced that the first patient has been treated in its Phase 1 trial evaluating safety, tolerability, and...
Email
Text